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Abstract A subtype-specific impairment of cognitive
functions in spinocerebellar ataxia (SCA) patients is still
debated. Thirty-two SCA patients (SCA1, 6; SC2, 3; SCA3,
15; SCA6, 8) and 14 matched healthy controls underwent
neuropsychological evaluation testing attention, executive
functions, episodic and semantic memory, and motor
coordination. Severity of ataxia was assessed with the
Scale for the Assessment and Rating of Ataxia (SARA),
nonataxia symptoms with the Inventory of Non-Ataxia
Symptoms. Depressive symptoms were evaluated with the
Beck Depression Inventory. The SARA scores of our SCA
patients (range 1–19.5) indicated an overall moderate
ataxia, most pronounced in SCA6 and SCA1. Mean number
of nonataxia symptoms (range 0–2.2) were most distinct in
SCA1 and nearly absent in SCA6. SCA1 performed poorer
than controls in 33% of all cognitive test parameters,
followed by SCA2, SCA3, and SCA6 patients (17%). SCA
1–3 patients presented mainly attentional and executive
dysfunctions while semantic and episodic memory func-
tions were preserved. Attentional and executive functions
were partly correlated with ataxia severity and fine motor
coordination. All patients exhibited mildly depressed mood.
Motor and dominant hand functions were more predictive
for depressed mood than cognitive measures or overall
ataxia. Besides motor impairments in all patients, SCA
patients with extracerebellar pathology (SCA 1–3) were
characterized by poor frontal attentional and executive
dysfunction while mild cognitive impairments in predom-
inantly cerebellar SCA6 patients appeared to reflect mainly
cerebellar dysfunction. Regarding the everyday relevance
of symptoms, (dominant) motor hand functioning emerged
as a marker for the patient’s mood.
Keywords Spinocerebellar Ataxia (SCA).Cerebellum.
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Introduction
The spinocerebellar ataxias (SCAs) are a clinically and
genetically heterogeneous group of autosomal-dominantly
inherited neurodegenerative disorders, characterized by
prominent ataxia and cerebellar atrophy. Up to now, almost
30 different gene loci have been identified. In six SCAs
(SCA 1, 2 3, 6, 7, 17) the mutation is a translated CAG repeat
expansion coding for an elongated polyglutamine tract within
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can either be rather limited to the cerebellum (e.g., in SCA6)
ormayinvolvefurtherextracerebellarstructures,asinSCA1–
3, the most common forms of SCA [1].
A possible subtype-specific impairment of cognitive
functions in SCA patients is still debated [2, 3]. SCA1, 2,
and 3 are associated with deficits in executive functions and
verbal memory [4], and additional impairments in visual
memory, visuoconstruction, and visual attention have been
described in SCA3 [5–7]. Burk et al. documented dementia
in 25% of one SCA2 sample and impairments in verbal
memory and phonemic word fluency in a non-demented
SCA2 group [8]. Recently, cognitive impairments were also
reported in SCA6 patients [9, 10].
The sole function of the cerebellum as a motor control
structure has been questioned in several studies, and cognitive
functions have been ascribed to it in addition [11–14].
Anatomical studies described connections between the
cerebellum and prefrontal lobe via cerebello-ponto-
thalamico-cortical pathways [15]. PET and fMRI studies
showed evidence of cerebellar activation during pure
cognitive tasks [16–18]. Clinical studies further suggested
participation of the cerebellum in executive functions, like
selective attention, strategic planning, decision making, and
working memory. Even behavior associated with frontal lobe
functioning like control of affect is related to functioning of
the cerebellum [19]. Other studies emphasized normal
cognitive functions in patients with cerebellar disorders or
attributed cognitive deficits to additional extracerebellar
involvement [20, 21]. The major difficulty in comparing
cognitive properties of cerebellar disease patients is the
heterogeneity of extracerebellar involvement. Therefore,
Timmann and Daum proposed a comparison of patients with
purely cerebellar disorders in order to determine the specific
cerebellar contribution to cognition [22]. We tried to execute
this proposal by comparing cognitive profiles of predomi-
nantly cerebellar disease patients (SCA6) with patients that
show additional extracerebellar involvement (SCA 1–3).
The aim of the present study was to clarify (1) whether
patients with SCA 1, 2, 3, and 6 have cognitive impairments
regarding attention, executive functions, episodic, and seman-
tic memory; (2) whether these impairments are independent
from motor control problems; and (3) to evaluate a possible
SCA subtype-specific pattern of cognitive deficits.
Materials and Methods
Participants
The study comprised two asymptomatic SCA1 carriers and
32 SCA patients, selected from the SCA outpatient clinic of
the Department of Neurology, University Hospital of Bonn.
All patients were examined neurologically and rated
according to the Scale for the Assessment and Rating of
Ataxia (SARA) and the Inventory of Non-Ataxia Symp-
toms (INAS) [23, 24]. Two female asymptomatic SCA1
carriers, six patients with SCA1, three with SCA2, 15 with
SCA3, and eight with SCA6 were investigated. Fourteen
healthy matched controls for age, sex, and IQ—mostly
spouses of the patients—served as controls. Further patient
characteristics are given in Table 1.
All subjects were tested with an extensive neuropsycho-
logical test battery comprising tests of attention, executive
functions, episodic and semantic memory, and motor
control. All subjects signed informed consent. The study
was approved by the Ethics Committee of the University of
Bonn.
Neuropsychological Battery
Attention
Processing speed was examined with a symbol-counting
task (subtest 1 of the c.I. Test)[ 25] and psychomotor speed
by a simple and a choice reaction time task which are part
of the computerized neuropsychological screening test
battery NeuroCogFX [26].
Executive Functions
– Phonemic verbal word fluency was assessed via a
German oral word-fluency test (subtest 6 of the
Leistungsprüfsystem)[ 27]. Subjects had to generate as
many words as possible starting with a given letters
within 1 min. This was done three times with different
letters. The total sum of words was the variable of
interest.
– The subtest response inhibition of the c.I. Test requires
inverse reading of a string of the letters A and B (e.g.,
AABAB as BBABA) [25]. The time needed to read the
two rows including the time needed for corrections
represent the score.
– Inverse choice reaction with a reversion of the target
and non-target stimuli was tested with the NeuroCogFX
computer test [26]. Besides reaction time, the number
of errors was assessed.
– Planning was assessed via the Tower of Hanoi [28].
This task requires shifting of a tower consisting of four
disks with increasing size from one peg (out of three)
to another peg under the condition that no larger disk
is placed on top of a smaller one. The number of
trials needed to complete the test was the dependent
measure.
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– Verbal memory was assessed with the VLMT (Verbaler
Lern- und Merkfähigkeitstest, [29]) a German version
of the Rey Auditory-Verbal Learning Test. A list of 15
nouns is to be learned and immediately recalled in five
consecutive trials. This is followed by learning and
immediate recall of a second word list in one trial,
unexpected free recall after distraction, and again after
a 30-min delay and a recognition trial in which learned
words are to be recognized from a list with distractors.
From all possible scores of this test, the total number of
words correctly recalled after a delay of 30 min was
chosen as the parameter of interest (“verbal memory”)
since this is the most sensitive and most representative
score for the assessment of verbal long-term memory
[30].
– Figural memory was assessed by a revised version of
the Diagnosticum für Cerebralschädigung [31]. This
list-learning test requires learning and reproduction of
Table 1 Means and standard deviations (SD) of neuropsychological test performance in SCA 1, 2, 3, 6 patients and controls
NP Test Controls (N=14) SCA1 (N=6) SCA2 (N=3) SCA3 (N=15) SCA6 (N=8)
(Mean±SD) (Mean±SD) (Mean±SD) (Mean±SD) (Mean±SD)
Clinical data
Sex (m/f) 7/7 3/3 0/3 9/6 6/2
Age [years] 48.1±11.8 45.7±9.9
b 53.0±4.6
b 42.2±9.6
b 60.0±8.9
b,c
Age of onset [years] – 36.3±7.6
b 44.7±3.2
b 37.2±11.0
b 51.0±6.8
b
Disease duration [years] – 9.3±6.4 8.3±1.5 5.7±3.5 9.0±5.4
Repeat length of exp. Allele – 47.2±3.5 36.0±0.0 71.7±3.9 21.7±0.8
SARA – 12.5±4.7 3.8±1.4 8.2±6.4 12.6±4.8
INAS 0.0±0.0 2.2±0.8 1.0±1.0 1.1±1.3 0.1±0.4
BDI 4.71±5.88 11±4.24
b,c 7±4.36 5.29±3.94
b 11.38±2.33
b,c
Handedness (right/left/both) 13/1/0 5/0/1 2/0/1 12/3/0 8/0/0
Motor functions
Gross motor coordination
a 4.79±1.21 8.00±2.10
c 5.30±1.53 5.86±3.21 8.88±3.72
c
Fine motor coordination
a 72±10.98 26.83±13.64
b,c 45±4.58
c 48.2±14.57
b,c 28.29±12.55
b,c
Attention
Processing speed
Symbol counting test
a[s] 16.64±2.74 29.00±10.18
b,c 21.00±1.00 21.73±5.96
b,c 25.75±8.60
c
Psychomotor speed
Simple+choice reaction [s] 336.31±62.27 463.00±69.82
c 508.33±170.01
c 395.61±137.15 408.71±114.12
Executive functions
Tower of Hanoi 29.43±6.91 29.08±9.33 24.50±5.29 29.00±8.64 27.94±9.51
Phonemic Word Fluency 13.17±4.44 9.22±2.21
c 11.44±4.86 8.73±2.86
c 10.17±4.34
Response Inhibition
a [s] 19.79±4.44 26.00±6.16 21.67±2.52 25.13±7.88 29.25±10.46
Inverse choice reaction [s] 385.23±77.27 565.60±137.60
c 652.67±213.38
c 456.07±132.54 507.57±146.88
Inverse choice errors
a 0.23±0.6 0.83±2.04
b 0±0
b 0.43±0.94
b 2.57±1.81
b,c
Episodic memory
Verbal memory 13±2.42 12±1.55 12.33±2.52 12.13±3.02 10.88±3.27
Figural learning 7.71±2.13 6.40±1.52 7±2 8±1.57 4.88±3
Semantic memory
Vocabulary: MWT-B-IQ 110.79±13.55 111.83±11.27 130.00±6.00 116.46±13.22 114.25±18.78
Boston naming test 57.67±2.53 54.5±2.67 58.33±2.73 56.36±2.73 55.29±4.19
Semantic word fluency test 21.29±5.62 15.50±4.18 17.67±4.16 17.33±5.77 18.00±5.29
SARA Scale for the Assessment and Rating of Ataxia, INAS Inventory of Non-Ataxia Symptoms
aMarks tests that correlate with ataxia severity
bSignificant differences between the patient groups in post-hoc analyses
cSignificant differences between a patient group with the control group
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consecutive learning trials by use of five sticks of equal
length. From this test, the number of correctly
reproduced designs in the last learning trial (learning
capacity) served as the parameter of interest (“figural
learning”). Since very poor performers often do not
proceed to the 6th trial, this parameter best reflects the
performance in this test.
Semantic Memory
– The Mehrfachwahl Wortschatz Interferenztest (MWT-B)
is a vocabulary test which comprised 37 rows com-
posed of four words and required word vs. non-word
recognition [32]. Performance on this test is a good
indicator for crystallized intelligence and highly corre-
lated with the level of education.
– The Boston Naming Test requires confrontation naming
and also reflects semantic memory by means of
crystallized intelligence [33]. Sixty line drawings are
to be named and the number of incorrect answers
served as outcome parameter.
– Finally, categorical semantic word fluency for animals
in a 60-s interval was assessed.
Motor Functions
– Gross motor coordination was examined with a motor
sequencing task adopted from Luria [34]. This task
requires rapid alternation of uni- and bimanual motor
sequences. The sum of the four subscores was used as
the total score with higher scores representing poorer
performance (score range 4–16 points). Procedure and
scoring of this test have been described elsewhere [35].
– Fine motor coordination was assessed with the Purdue
Pegboard [36]. The participant had to plug as many
pegs as possible into small holes vertically arranged on
a Pegboard using either left or right hand and both
hands simultaneously. A fourth test required an
assembly using both hands. These scores were merged
into one total score with higher scores representing
better performance.
Ataxia Severity
The SARA is based on a semiquantitative assessment of
cerebellar ataxia and includes eight items (gait, stance,
sitting, speech disturbance, finger chase, nose-finger test,
fast alternating hand movements, heel-shin slide). It yields a
total score from 0 (no ataxia) to 40 (very severe ataxia).
Scale validation studies in the past demonstrated a good
correlation with disease stages [23, 37, 38].
Nonataxia Symptoms
Nonataxia symptoms were assessed with the INAS. The
INAS is a clinical description counting presence or absence
of 16 binary variables up to a simple sum score of
nonataxia symptoms in each patient [24].
Depression
The Beck Depressive Inventar (BDI) measures emotional
distress rather than major depression and, therefore, serves
as an indicator of depressed mood [39]. This test consists of
21 questions reflecting the most frequent symptoms of
depression. Eleven points and above are defined as a mild
depressed mood while 18 points and more correspond to a
more severe form of depressed mood.
Statistical Analysis
Statistical comparisons were conducted by separate one-
way ANOVAs and ANCOVAs specifying group as inde-
pendent variable and the respective test scores of the
cognitive domains as dependent variables. Post hoc paired
group comparisons were measured with the Fisher’s least
significant difference (LSD) test.
The groups differed significantly in age and age at
disease onset. To differentiate disease related from normal
age related cognitive decline, age correction was included
as a covariate in all ANCOVA. Differences with p<0.05
were considered as significant. The scores for “gross motor
coordination” and “errors” in the inverse choice reaction
task were not normally distributed. For these measures,
nonparametric Mann–Whitney U tests were calculated
additionally. The χ
2 test was used to compare nonparamet-
ric ataxia scores and the distribution of sexes. Correlation
analyses were conducted using linear regression analysis
between the SARA score and each test result of the
patients, BDI score, disease duration, age at onset of
disease, sex of the patient, and repeat length of the
expanded allele. Moreover, we also calculated correlations
between fine motor coordination and all test scores of the
patients.
For an overall comparison of the cognitive impair-
ment between the different patient subgroups, a sum-
mary score was calculated by summing up all cognitive
tests exhibiting significant differences between the
patient subgroup and controls in the analyses described
above. Twelve test scores were taken into account (see
Table 1). Finally, taking published normative data as
reference, patient scores were rated as impaired versus
unimpaired when standardized test scores were below or
within the range of the mean±1.5 standard deviation of the
norm.
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Chi-squaretestingshowedequalsexdistributioninallgroups.
ANOVA revealed significant differences in age (p=0.005)
and age at disease onset (p=0.009) but no difference
regarding disease duration (see Table 1). SCA6 patients
were significantly older and had a later disease onset
compared to all other groups (see Table 1).
Summing up all cognitive test scores in which patients
deviated significantly from controls, we found only mild
cognitive impairment. SCA1 patients had deficits in four out
of 12 cognitive test scores (33%), SCA2, SCA3, and SCA6 in
two out of 12 tests parameters (17%), respectively. Both
asymptomatic SCA1 gene carriers had normal results in all
cognitive, emotional, and motor tests (data not shown).
Deviations of patients from healthy controls in different
neuropsychological domains (expressed by Z scores) are
illustrated in Fig. 1.
Attention and Reaction Times
Groups (patient groups and controls) differed significantly
in processing speed as assessed by symbol counting (F
(4,40)=4.880, p=0.003). LSD post hoc comparison
revealed that SCA1 (p<0.0001), SCA6 (p=0.013), and
SCA3 (p=0.022) patients performed significantly slower
than controls. Moreover, SCA1 performed significantly
worse than SCA3 (p=0.03).
All SCA1 patients (100%), 67% of SCA2 patients, 80%
of SCA3 patients, and 75% of our SCA6 patients
performed below test norms.
Groups also differed significantly in psychomotor
speed (F(4, 36)=2.667, p= 0 . 0 4 8 ) .A c c o r d i n gt op o s th o c
analysis, SCA1 (p=0.013) and SCA2 (p=0.031) patients
showed slower reaction times than controls (Table 1).
Evaluating simple and choice reaction times separately
and comparing them to test norms, SCA1 (60%/60%) and
SCA2 (67%/67%) showed longer simple and choice
reaction times more frequently than SCA3 (21%/50%) or
SCA6 (43%/14%).
Executive Functions
Groups did not differ in their performance on the Tower of
Hanoi task, not one patient scored within the impairment
range. Groups did, however, significantly differ in phone-
mic verbal fluency (F(4, 40)=2.989, p=0.03). Post hoc
comparison revealed that SCA1 (p=0.033) and more
distinctly SCA3 (p=0.002) patients produced significantly
fewer words than controls. In contrast to the Tower of
Hanoi task, all patients were rated as impaired according to
the test norms in this task.
Nosignificant differencesbetweengroupsweredetectedin
response inhibition, (F(4, 40)=2.419, p=0.064). However,
LSD post hoc comparisons showed a trend for mild deficits
in SCA3 and SCA6 when compared to controls (p=0.018
and p=0.041). Categorization of patients into impaired/
unimpaired patients revealed that 50% of SCA1 patients,
47% of SCA3, and 67% of SCA6 showed impaired
performances. SCA2 subjects were not impaired when
compared to test norms.
Performance was different among groups in the inverse
choice reaction task (F(4, 36)=3.863, p=0.01). SCA1 (p=
0.005) and SCA2 (p=0.004) showed a significantly poorer
performance than controls did.
SCA6 patients did not show any prolonged reaction
time, but they produced more errors during the inverse
choice reaction task than every other patient or control
group; main effect: (F(4, 37)=5.268, p=0.002), post hoc
comparisons: (controls (p<0.0001), SCA1 (p=0.014),
SCA2 (p=0.002), SCA3 (p<0.0001)). Mann–Whitney U
testing revealed the same results. When compared to test
norms, not only SCA1 (80%) and SCA2 (67%) but also
29% of SCA3 and 43% of SCA6 patients showed impaired
performances.
Episodic and Semantic Memory
Group differences were found neither in verbal or visual
memory nor in the vocabulary test MWT-B, confrontation
naming task, and semantic word fluency test (Table 1).
Gross Motor Coordination
Fine Motor Coordination
Attention
Executive Functions
Episodic Memory
Semantic Memory
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Fig. 1. Neuropsychological deficits of SCA 1, 2, 3, and 6. Deviations
of patients from healthy controls in different neuropsychological
domains are expressed by Z scores
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patients, respectively, scored below the norms in the total
number of words recalled after a delay of 30 min (verbal
memory). Figural learning was impaired in two SCA6
patients (25%) when compared to test norms. No patient
performed below the norm in the vocabulary test MWT-B.
Only one SCA6 patient performed below the norms in the
confrontation naming task. Patients were more frequently
impaired in semantic fluency when compared to test
norms: 50% of SCA1, 33% of SCA2, and 27% of SCA3
patients scored at least 1.5 standard deviations below the
norm. No SCA6 patients showed deviation from the norm
in this test.
Motor Function
All but one control subject (93%) were right-handed as
compared to 27 of the 32 patients (84%; Fisher Test p=0.45).
The task on gross motor coordination produced signif-
icant group differences (F (4, 39)=3.047, p=0.028). SCA1
(p=0.008) and SCA6 (p=0.015) scored worse than con-
trols. Mann–Whitney U testing revealed the same results.
When compared to test norms, 83% of SCA1, 33% of
SCA2, 14% of SCA3, and 75% of SCA6 patients scored
below test norms.
Groupsalsodifferedinfinemotorcoordination(F (4, 45)=
14.305, p<0.0001). All patient groups, SCA1 (p<0.0001),
SCA2 (p=0.003), SCA3 (p<0.0001), and SCA6 (p<0.0001)
performed significantly worse than controls. Additionally,
SCA1 (p=0.008) and SCA6 (p=0.011) performed worse
than SCA3. When compared to normative data, nearly all
patients were impaired. Only three SCA3 patients (20%)
showed an average performance in the subtest executed
with the dominant hand (two right-handed and one left-
handed patient). One of these patients and additionally
one SCA6 patient scored normal in the assembly subtest.
In all other subtests, all patients scored at least 1.5 SDs
below the norm.
Evaluating to which degree the impairment of fine motor
coordination affects cognitive functions, significant corre-
lations were mainly found with tests that exhibit speed
components like symbol counting (r=0.71, p<0.0001),
simple and choice reaction time (r=0.48, p=0.009),
response inhibition (r=0.67, p<0.0001), inverse choice
reaction time (r=0.46, p=0.013), and semantic word
fluency (r=0.39, p=0.03).
Ataxia
The mean SARA score was 9.3 (range 3.8–12.6) and most
severe in SCA6 (12.6) and SCA1 (12.5) followed by SCA3
(8.2) and SCA2 (3.8). These differences were not signifi-
cant (F (3, 31)=2.776, p=0.06).
Significant correlations were found between ataxia
severity (SARA scores), performance on symbol counting
(r=0.57, p=0.001), response inhibition (r=0.45, p=0.01),
and number of errors during the inverse choice reaction
task (r=0.45, p=0.002). The correlation between ataxia
severity and gross and fine motor coordination was also
significant (r=0.52, p=0.003 and r=0.6, p<0.0001,
respectively). All other tests did not significantly correlate
with the SARA scores. Regarding the patient character-
istics, neither disease duration nor age at disease onset,
sex, or repeat length showed significant correlations with
ataxia severity.
Nonataxia Symptoms
The mean number of nonataxia symptoms ranged between
0 and 2.2 and were more often present in SCA1 (2.2),
SCA2 (1.0), and SCA3 (1.1) and nearly absent in SCA6
(0.1). Found nonataxia symptoms included mostly areflexia
(legs), sensory symptoms (legs), and brainstem oculomotor
signs. In single patients, muscle atrophy (legs), rigidity (in
one SCA3 patient), spasticity (legs), dystonia (torticollis in
one SCA1 patient), or urinary dysfunction was docu-
mented. Since the INAS score merely counts symptoms
and is not a true scale, no further correlation analyses were
performed.
Depression
The SCA groups differed significantly in degree of
depressed mood as assessed with the BDI (F (4, 40)=
3.81, p=0.01). Post hoc group comparison revealed that
SCA1 and SCA6 showed more pronounced depressed
mood than controls and SCA3 (p value ranging between
0.014 and 0.005).
No patient showed scores indicating severely depressed
mood (BDI score ≥18). Mildly depressed mood (BDI score
11–18) was indicated in 75% of SCA6 patients, 50% of
SCA1 patients, 33% of SCA2 patients, and 13% of SCA3
patients. Interestingly, 14% of controls scored between 11
and 18 points. All other participants scored below 11 points
in the BDI questionnaire, which corresponds to no
depressive symptoms.
The correlation between patient’sS A R Aa n dB D I
scores was not significant (r=0.32, p=0.073). However,
when taking the test data into account, depressed mood
was highly correlated with gross and fine motor coordi-
nation (r=0.52–0.54, p<0.03–0.002). Taking dominant
and non-dominant hand motor functions separately into
consideration, depressed mood was mostly correlated with
dominant hand performance (hand performance in gross
and fine motor coordination: dominant: r=0.5–0.63, p<
0.005–0.0001; non-dominant: r=0.38–0.58, p<0.03–
438 Cerebellum (2010) 9:433–4420.0001). Apart from figural learning (r=0.43, p=0.01),
response inhibition (r=0.42, p=0.02), and inverse choice
reaction (r=0.38, p=0.04), none of the remaining test
parameters on attention, speed, fluency, naming, planning,
vocabulary, or verbal memory were significantly correlat-
ed with BDI scores.
Discussion
SCA patients primarily suffered from motor problems of
different degrees. The SARA scores of our SCA patients
ranged between 1 and 19.5 (SCA1 5.5–17, SCA2 3–5.5,
SCA3 1–18, SCA6 4.5–19.5) indicating an overall
moderate ataxia. Accordingly, all patients showed prob-
lems in distal fine motor coordination. Problems in
gross motor coordination (proximal) were evident in
g r o u pc o m p a r i s o no n l yi nS C A 1a n dS C A 6p a t i e n t s
who also exhibited the most severe ataxia. Nonataxia
symptoms were only present in SCA1, 2, 3 and one
individual SCA6 patient. These symptoms mainly
included brainstem oculomotor signs and areflexia/
sensory symptoms of legs—most likely due to SCA-
related polyneuropathy.
Regarding the core question of this study, we observed
cognitive impairments in our SCA patients, particularly in
frontal attentional and executive functions. Three tests
(symbol counting, response inhibition, and number of
errors in inverse choice reaction) correlated with ataxia
severity (SARA score) whereas all other tests appeared
largely ataxia-independent. Fine motor coordination, as
the most sensitive indicator for motor impairment in SCA,
was correlated to tests requiring a speed component but
affected only one out of the three measures of executive
function which differentiated patients from controls
(inverse choice reaction).
Going into more detail, SCA1 patients showed the
broadest range of impairments in that they scored poorer
than controls in 33% of all cognitive test parameters.
Patients with SCA2 and SCA3 in contrast showed
impairments in only 17% of test scores. The pattern of
impairment with reduced processing speed and prolonged
reaction times (attention), reduced phonemic verbal
fluency, and reduced cognitive flexibility (executive
functions) strongly suggests frontal lobe associated im-
pairment of executive functions in SCA1, 2, and 3. Taking
published normative data as the reference, semantic
fluency was partly impaired in SCA1, 2, and 3, not in
SCA6. Considering the fact that no such difference was
seen between patients and controls or within the patient
groups, we tend to interpret this result to be due to the test
norm selection rather than to true group differences. Since
the two asymptomatic SCA1 carriers showed normal
cognitive test scores, cognitive dysfunction does not seem
to precede cerebellar ataxia.
In contrast to other reports, our group comparison did
not confirm previously documented impaired verbal mem-
ory in SCA1, 2, and 3 [4, 8, 40, 41]. Whereas the SCA2
group was too small to allow reliable conclusions from
these results, SCA1 and SCA3 patients were clearly found
to be unimpaired. Since the performance in the Rey
Auditory Verbal Learning Test has been demonstrated to
be strongly related to temporal lobe function, we would
suggest that temporal lobe memory function is rather
preserved in SCA.
But why did other groups find distinct verbal memory
impairment in SCA? A possible explanation may be seen in
the fact that different memory tests had been used in the
different studies. This is important, since the California
Verbal Learning Test, the Wechsler logical memory,o rDigit
Span from the Wechsler Memory Test have much stronger
demands on working memory, language processing, and
executive functions (organization of learning) than the Rey
Auditory Verbal learning test which was used here [42].
Accordingly, these tests must be assumed to pick up the
executive impairments in SCA.
Contradictory results may also arise from the heteroge-
neity of the SCA phenotypes. The presence of nonataxia
symptoms is well known in SCA1, 2, and 3 and although a
subtype specific pattern of nonataxia symptoms exists, the
individual presence or absence varies [24]. As a conse-
quence, the influence of these symptoms on the individual
neuropsychological performance and subgroup result is
difficult to judge. We assessed nonataxia symptoms in our
patient sample with INAS and found brainstem oculomotor
signs and signs of polyneuropathy as the most frequently
observed nonataxia symptoms in our SCA1, 2, and 3
samples. Brainstem oculomotor signs may have an impact
on task execution and performance, respectively, especially
in combination with cerebellar oculomotor dysfunctions,
found in most SCA patients. It seems, however, unlikely
that the observed signs of polyneuropathy, reflecting
neuropathological changes at the level of spinal cord or
peripheral nerves, have impact on the neuropsychological
performance of our patients. However, nonataxia symptoms
only observed in single subjects of our patient groups
(especially spasticity, rigidity, or torticollis) reflect a more
pronounced supratentorial pathology, eventually associated
with reduced cognitive abilities in the affected individuals.
All SCA subgroups showed hints of depressed mood.
The expression of the indicated mood problem was mild,
and not a single patient showed a score indicative for a
more severe depression. SCA1 and SCA6 patients who also
suffered from the most severe ataxia appeared more
affected than the other groups. While no relation between
SARA scaling and mood was indicated, highly significant
Cerebellum (2010) 9:433–442 439correlations became evident for gross and fine motor
coordination. The highest correlation was found to right,
i.e., the dominant hand functioning for our group. Apart
from three scores on tests involving visual memory or
executive functioning (figural learning, response inhibi-
tion, and inverse choice reaction), none of the remaining
test parameters were correlated to depression scores. It
should be noted that this correlation pattern is not
characteristic for patients with major depression who
often present nonspecific slowing and diffuse cognitive
impairment interrelated with severity of depression. Thus,
in line with literature, depression in SCA appears reactive
to the perceived motor impairment rather than an organic
consequence of the disease [43]. Elevated depression
scores in the control group—mostly patient’ss p o u s e s —
may well be discussed as a reflection of being affected by
the patient’s disease.
Patients with SCA6, neuropathologically regarded as a
predominantly cerebellar syndrome, showed significant
impairments in only two cognitive scores, symbol counting
(attention), and the amount of errors in the inverse choice
reaction task (executive function). A nonsignificant trend
only pointed towards further executive dysfunction in the
test response inhibition, but all three scores are related to
motor impairment and/or ataxia severity. Poor performance
in these tests can either be explained by motor problems
during task execution or by a cerebellar involvement in
cognitive operations. Given that one of the three tests
requires fast visuomotor search (symbol counting) and
deficits were found in all other SCA groups, cerebellar
occulomotor problems may explain this finding [44]. The
SCA6 sample was older than our control group, and it
cannot be ruled out that our findings in SCA6 are attributed
to the age difference between both groups. However, the
comparison to age-corrected normative data rather supports
the idea of impairment. SCA6 patients made more errors in
the inverse choice reaction task than the other SCA groups.
Prolonged reaction times present in other SCA groups but
not in SCA6 may assist in avoiding errors and could be a
possible explanation for increased error rates being found
only in SCA6 and not in other SCA groups. Whether
prolonged reaction times are caused by SCA-type-specific
pathology or rather reflect an acquired compensatory
mechanism remains to be determined.
The question of a cerebellar contribution to cognitive
operations like attention and executive functions is still
under discussion [14]. The cerebellum projects via
cerebello-ponto-thalamo-cortical pathways to the frontal
cortex [15] and loss of cerebellar efferents to the cortex
might cause cognitive impairments. This hypothesis is
supported by studies in healthy subjects and patients with
cerebellar lesions describing severe cognitive and emo-
tional disturbances in patients with isolated cerebellar
pathology [11, 45, 46]. However, apart from two studies
which documented impairments of visual memory, pho-
nemic, and semantic verbal fluency and cognitive flexi-
bility in parallel to a cerebellar and prefrontal
hypoperfusion [9, 10], other publications found normal
cognitive functioning or only trends towards mild frontal
deficits in SCA6 [47]. Differences regarding the acuity of
cerebellar damage or involved cerebellar regions can be
considered as possible explanations. Acute cerebellar
lesions may have qualitatively different consequences for
cognition and emotion as opposed to slow progressive
degenerations like in SCA6. Furthermore, ischemic or
traumatic lesions may affect more cerebellar tissue—white
matter or cerebellar nuclei—than degeneration in SCA6,
in which mainly Purkinje cells are involved. The idea of a
cerebellar involvement in cognitive functioning is strongly
supported by our finding of significant abnormal test
results in comparison to published norms in SCA6 that
seem to exceed motor impairment. Motor-independent
cognitive tests in pure cerebellar patients with either acute
or chronic damage are indispensable to further clarify the
role of the cerebellum in cognition.
Conclusion
In sum, our results for SCA1, SCA2, and SCA3 patients
point towards motor independent neuropsychological
impairments of frontally associated functions rather than
temporal lobe related functions: although an impact of a
subtype-specific pattern of cerebellar pathology, e.g., the
involvement or sparing of Purkinje cells or dentate nucleus,
cannot be ruled out, we suggest that the more pronounced
cognitivemotorindependentimpairmentsinSCA(1,2,and3)
patients are mainly attributable to extracerebellar degenera-
tion. As thalamic or basal ganglia pathology has been
described in all three subtypes (but not in SCA6), disruption
of basal ganglia-thalamocortical loops may well be the
morphological substrate for the observed cognitive impair-
ment in these subtypes [3, 48–50]. However, concerning
every day relevance for SCA patients, cognitive impairments
did—in contrast to (dominant) motor hand functioning—not
appear to affect the patient’sm o o d .
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